Replies to post #2529 on NightHawk Biosciences Inc (NHWK)

[dia76ca]

oltimer,

I wonder if Saturday's SITC presentation will be entirely new ComPACT preclinical data? There is already some very positive preclinical ComPACT data on the companies current slide presentation.
I was surprised that they have not released any new NSCLC data...perhaps they are holding it back so that it can be released after the sale of the new shares...so that the new shareholders can enjoy the increased share price.
And, of course, the big news will come out after they meet with the FDA....sometime later this month. What will be the approval pathway for a drug that dramatically increases the efficacy of Opdivo...without adding any harmful side effects?

AND will they PARTNER for phase III...and to get ComPACT into the clinic? Many questions and much good news to come IMO.